Sancuso

Active Ingredient(s): Granisetron
FDA Approved: * September 12, 2008
Pharm Company: * STRAKAN INTL
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Sancuso Overview

Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and Radiotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors. Granisetron was developed by chemists working at the British dr...

Read more Sancuso Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Granisetron

Recent Sancuso Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Granisetron
  • Film, Extended Release: 3.1mg/24hr
  • Injection: (1mg/ml) 1mg/1ml, (1mg/ml) 4mg/4ml, 0.1mg/ml, 0.1mg/ml (0.1mg/ml), 10mg/0.4ml, 1mg, 1mg/ml, 1mg/ml (1mg/ml), 3mg/ml, 4mg/4ml (1mg /ml), 4mg/4ml (1mg/ml)
  • Injection, Extended Release: 10mg/0.4ml (10mg/0.4ml)
  • Solution: 2mg/10ml
  • System: 3.1mg
  • Tablet: 1mg, 2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sancuso: (2 results)

Sorted by National Drug Code
  • 42747-726 Sancuso 3.1 mg/24h Transdermal Patch by Prostrakan, Inc.
  • 54868-5985 Sancuso 3.1 mg/24h Transdermal Patch by Physicians Total Care, Inc.

Other drugs which contain Granisetron or a similar ingredient: (3 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA